S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › ALKAL › Research report
← ALKAL page
XStocksXray
Market X-Ray report · 19 October 2026

Kalray SA (ALKAL)

Euronext Paris · France · prices in EUR · close of 19 Oct 2026

Key indicators

Last closeEUR 3.710
52-week range0.640 – 16.000
Return, 1 month / 3 months−28.4% / −55.3%
Return, 1 year / 3 years+282.5% / −79.0%
TrendBelow its 200-day average
RSI (14)26
Volatility (1 year)124.4%
Worst drawdown (1 year)-74.5%
Average daily value traded0.96M EUR
Dividend yield–

Market X-Ray price-based

29/ 100 · High confidence · ahead of 18% of stocks on this exchange
Trend12
Momentum38
Stability (higher is calmer)7
Liquidity79
Income–

Five-year price chart navy: price · brown: 200-day average

-1.658.0317.7127.3937.072021-112023-022024-052025-072026-10

About the company

Kalray is a French semiconductor company that designs manycore processors and acceleration cards built around its massively parallel processing architecture. Its chips and smart network cards handle data-intensive computing tasks for customers in data centres, networking and storage, as well as embedded systems used in vehicles and aerospace. The company is based in France, near Grenoble, and works with hardware and software partners to bring its processing technology into commercial systems.

On this site Kalray SA appears as a stock on the Euronext Paris (France), code ALKAL, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Kalray SA (ALKAL) trades on the Euronext Paris in France. It last closed at EUR 3.710 on 19 October 2026.

Its price-based Market X-Ray is 29 out of 100 (a weak price profile), ranking 513 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 282.5% and over the last three months it fell 55.3%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Kalray SA (ALKAL)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend12 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-39.9%
From 52-week high-74.5%
Momentum38 · WeakLagging most stocks on this exchange.
3-month return-55.3%
6-month return-38.4%
12-month return, skipping the last month434.0%
Stability (higher is calmer)7 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)124.4%
Worst drawdown, 1 year (smaller is calmer)-74.5%
Liquidity79 · StrongTrades actively.
Average daily value traded0.96M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−11.2%
1 month−28.4%
3 months−55.3%
6 months−38.4%
1 year+282.5%
3 years−79.0%
5 years−89.2%

Signals

50-day / 200-day average5.317 / 6.172
Golden / death cross (60 days)Death, 11 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.359

Technical summary

DailyBearish4 bullish · 0 neutral · 12 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026